Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

An Examination of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Elderly Patients With Hypertension

ClinicalTrials.gov ID: NCT00412932

Public ClinicalTrials.gov record NCT00412932. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 7:08 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Open Label, Single Arm Study to Evaluation the Safety and Efficacy of an Olmesartan Medoxomil Based Treatment Regimen in Elderly Patients With Hypertension

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This 14 week study will examine the ability of olmesartan medoxomil to lower the blood pressure of patients 65 years of age or older with high blood pressure. The medication being tested has been approved by the FDA for the treatment of high blood pressure.

Study identification

NCT ID
NCT00412932
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Daiichi Sankyo
Industry
Enrollment
178 participants

Conditions and interventions

Eligibility (public fields only)

Age range
65 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 2006 (Type not available)
Primary completion
Apr 2008 (Actual)
Completion
Apr 2008 (Actual)
Last update posted
Sep 22, 2009

2006 – 2008

United States locations

U.S. sites
29
U.S. states
20
U.S. cities
29
Facility City State ZIP Site status
Not listed Birmingham Alabama — —
Not listed Mesa Arizona — —
Not listed Long Beach California — —
Not listed Los Angeles California — —
Not listed Pomona California — —
Not listed Roseville California — —
Not listed Tustin California — —
Not listed Farmington Connecticut — —
Not listed Jupiter Florida — —
Not listed Lauderdale Lakes Florida — —
Not listed New Port Richey Florida — —
Not listed Pembroke Pines Florida — —
Not listed Chicago Illinois — —
Not listed Wichita Kansas — —
Not listed Madisonville Kentucky — —
Not listed Auburn Maine — —
Not listed Baltimore Maryland — —
Not listed Oxon Hill Maryland — —
Not listed Florissant Missouri — —
Not listed Berlin New Jersey — —
Not listed Williamsville New York — —
Not listed Charlotte North Carolina — —
Not listed Cincinnati Ohio — —
Not listed Oklahoma City Oklahoma — —
Not listed Greer South Carolina — —
Not listed Corpus Christi Texas — —
Not listed Richardson Texas — —
Not listed Norfolk Virginia — —
Not listed Madison Wisconsin — —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00412932, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 22, 2009 · Synced Nov 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00412932 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →